Astronics is in a powerful long-term uptrend, with the stock up 179.8% over the past year, dramatically outperforming the S&P 500's 20.6% gain. The current price of $72.50 sits at 81.7% of its 52-week range ($21.76–$88.72), indicating the stock is in the upper half of its range but not yet at overbought extremes near the high. This positioning suggests sustained bullish momentum with room to run, though the recent pullback from the June high of $87.15 warrants caution. The stock's beta of 1.133 implies slightly higher volatility than the market, amplifying both upside and downside moves.

Short-term momentum shows conflicting signals: the 1-month price change of +5.7% is positive but decelerating from the 3-month change of +20.0%, and the stock has corrected sharply from its June 26 high of $87.15 to the current $72.50, a decline of nearly 17%. This divergence between the strong 1-year trend and the recent pullback could indicate a temporary mean-reversion move or profit-taking after a parabolic run. The relative strength versus the S&P 500 over 1 month is 1.59, suggesting the stock is still outperforming but losing steam relative to the market.

Key support lies near the 52-week low of $21.76, though more immediate support is around the $70 area, which held in early July. Resistance is at the 52-week high of $88.72; a breakout above that level would signal a resumption of the uptrend and could target $100+. Conversely, a breakdown below $70 would suggest further downside toward $60. The stock's beta of 1.133 means it is about 13% more volatile than the S&P 500, which investors should factor into position sizing and risk management, especially given the recent volatility spike.

Astronics has demonstrated a strong revenue growth trajectory, with the most recent quarterly revenue estimated at $1.074 billion (annualized), though specific quarterly figures are not provided. The company's 1-year price surge of 179.8% reflects market anticipation of accelerating growth, likely driven by a rebound in commercial aerospace deliveries and defense contracts. The revenue growth trend appears to be accelerating, as the stock's performance suggests improving fundamentals, though exact quarterly revenue and YoY growth rates are unavailable. The Aerospace segment, which generates the majority of revenue, is benefiting from increased aircraft production rates and aftermarket demand.

The company is profitable, with a net income margin of 3.4% and an EPS of $0.017 (likely diluted). Gross margin stands at 29.9%, while operating margin is 8.9%, indicating improving profitability as the company scales. Net income is positive, though the EPS is very low, suggesting the company is in the early stages of earnings recovery. Margins appear to be expanding from prior periods, as the stock's rally implies operational leverage, but specific historical margin comparisons are not available. The net margin of 3.4% is modest for the aerospace & defense industry, where peers often achieve double-digit margins, but the trajectory is positive.

The balance sheet shows a debt-to-equity ratio of 2.70, indicating significant leverage, which is common in capital-intensive aerospace manufacturing. The current ratio of 3.10 suggests strong liquidity, with current assets covering short-term liabilities more than three times over. Return on equity (ROE) is 20.96%, a strong figure that reflects efficient use of equity capital, though it is amplified by high leverage. Free cash flow data is not provided, but the PCF ratio of 23.25 implies the market values the company at 23x cash flow, suggesting positive cash generation. The high debt-to-equity ratio warrants monitoring, but the strong current ratio and positive ROE indicate manageable financial risk.